Study on inhibition of Britannin on triple-negative breast carcinoma through degrading ZEB1 proteins-Reference-Cited by-同舟云学术

Study on inhibition of Britannin on triple-negative breast carcinoma through degrading ZEB1 proteins

Published:2022-09 Issue: Volume:104 Page:154291
ISSN:0944-7113
Container-title:Phytomedicine
language:en
Short-container-title:Phytomedicine

Author:

Lu Hong,Wu Zhengyu,Wang Yijun,Zhao Di,Zhang Biyun^ORCID,Hong Mei

Publisher

Elsevier BV

Subject

Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine

Reference25 articles.

1. Schlafen12 reduces the aggressiveness of triple negative breast cancer through post-transcriptional regulation of ZEB1 that drives stem cell differentiation;Al-Marsoummi;Cell. Physiol. Biochem.,2019

2. The ubiquitin ligase Siah is a novel regulator of Zeb1 in breast cancer;Chen;Oncotarget,2015

3. The suppressive effects of Britannin (Bri) on human liver cancer through inducing apoptosis and autophagy via AMPK activation regulated by ROS;Cui;Biochem. Biophys. Res. Commun.,2018

4. EMT transcription factors in cancer development re-evaluated: Beyond EMT and MET;Goossens;Biochimica et biophysica acta. Rev. Cancer,2017

5. Anticancer activity of Britannin through the downregulation of cyclin D1 and CDK4 in human breast cancer cells;Hamzeloo-Moghadam;J. Cancer Res. Therapeut.,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Britanin – a beacon of hope against gastrointestinal tumors?;World Journal of Clinical Oncology;2024-04-24

2. Britannin inhibits cell proliferation, migration and glycolysis by downregulating KLF5 in lung cancer;Experimental and Therapeutic Medicine;2024-01-22

3. Britannin as a novel NLRP3 inhibitor, suppresses inflammasome activation in macrophages and alleviates NLRP3-related diseases in mice;Acta Pharmacologica Sinica;2024-01-03

4. Research progress on antitumor mechanisms and molecular targets of Inula sesquiterpene lactones;Chinese Medicine;2023-12-18